Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Practice Point
  • Published:

Can low doses of contrast agent be safely used for arteriovenous fistula salvage in stage 4 chronic kidney disease?

Nature Clinical Practice Nephrology volume 2, pages 618–619 (2006)Cite this article

boxed-textKian K et al. (2006) Safety of low-dose radiocontrast for interventional AV fistula salvage in stage 4 chronic kidney disease patients. Kidney Int 69: 1444–1449

Background

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Pisoni RL et al. (2002) Vascular access use in Europe and the United States: results from the DOPPS. Kidney Int 61: 305–316

    Article  Google Scholar 

  2. Lee T et al. (2004) Associations with predialysis vascular access management. Am J Kidney Dis 43: 1008–1013

    Article  Google Scholar 

  3. MacRae JM et al. (2004) Arteriovenous fistula-associated high-output cardiac failure: a review of mechanisms. Am J Kidney Dis 43: e17–e22

    Article  Google Scholar 

  4. Allon M and Robbin ML (2002) Increasing arteriovenous fistulas in hemodialysis patients: problems and solutions. Kidney Int 62: 1109–1124

    Article  Google Scholar 

  5. Miller CD (2003) Gender differences in outcomes of arteriovenous fistulas in hemodialysis patients. Kidney Int 63: 346–352

    Article  Google Scholar 

  6. Lameire NH (2006) Contrast-induced nephropathy—prevention and risk reduction. Nephrol Dial Transplant 21 (Suppl 1): i11–i23

    Article  CAS  Google Scholar 

  7. Frennby B et al. (1995) The use of iohexol clearance to determine GFR in patients with severe chronic renal failure—a comparison between different clearance techniques. Clin Nephrol 43: 35–46

    CAS  PubMed  Google Scholar 

Download references

Acknowledgements

The synopsis was written by Christiane M Erley, St Joseph-Krankenhaus, Berlin, Germany.

Author information

Authors and Affiliations

  1. St Joseph-Krankenhaus, Berlin, Germany

    Christiane M Erley

Authors
  1. Christiane M Erley
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Christiane M Erley.

Ethics declarations

Competing interests

The author declares no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Erley, C. Can low doses of contrast agent be safely used for arteriovenous fistula salvage in stage 4 chronic kidney disease?. Nat Rev Nephrol 2, 618–619 (2006). https://doi.org/10.1038/ncpneph0297

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncpneph0297

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing